{
    "N/R/U": null,
    "Applicant": "CSL Behring AG",
    "BLA Number": "102367",
    "Proprietary Name": "Carimune, Carimune Nf, Panglobulin, Sandoglobulin",
    "Proper Name": "Immune Globulin Intravenous (Human)",
    "BLA Type": "351(a)",
    "Strength": "3G",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "27-Jul-00",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "1055",
    "Submission Type": "Supplement",
    "License Number": "1766",
    "Product Number": "3",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}